NPI: 1043292899 · POWELL, TN 37849 · General Acute Care Hospital · NPI assigned 11/17/2005
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 11/17/2005 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 128,295 | $6.92M |
| 2019 | 88,142 | $4.28M |
| 2020 | 75,131 | $3.33M |
| 2021 | 72,540 | $4.33M |
| 2022 | 57,370 | $3.74M |
| 2023 | 60,476 | $3.49M |
| 2024 | 44,527 | $2.59M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 43,654 | 37,066 | $11.01M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 48,524 | 42,722 | $9.55M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 7,363 | 5,617 | $2.19M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,275 | 5,068 | $1.75M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,845 | 1,410 | $628K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,502 | 4,114 | $557K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 4,700 | 1,581 | $382K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 21,052 | 17,898 | $283K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 57,840 | 47,481 | $165K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 437 | 370 | $160K |
| 96375 | Therapeutic injection; each additional sequential IV push | 10,094 | 8,450 | $154K |
| 87428 | 3,232 | 2,856 | $131K | |
| 80053 | Comprehensive metabolic panel | 52,250 | 43,585 | $126K |
| 93458 | 284 | 202 | $117K | |
| 95811 | 779 | 610 | $114K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 349 | 273 | $102K |
| 62323 | 603 | 518 | $99K | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 1,901 | 1,686 | $94K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 548 | 455 | $94K |
| G0378 | Hospital observation service, per hour | 875 | 642 | $91K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6,085 | 5,232 | $79K |
| 84484 | 10,862 | 7,533 | $71K | |
| 36415 | Collection of venous blood by venipuncture | 58,192 | 46,332 | $51K |
| 96361 | Intravenous infusion, hydration; each additional hour | 8,382 | 7,125 | $49K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 6,961 | 5,860 | $47K |
| 59025 | Fetal non-stress test | 965 | 674 | $46K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 435 | 400 | $40K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 13,195 | 10,249 | $35K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,336 | 1,989 | $35K |
| 71045 | Radiologic examination, chest; single view | 12,803 | 10,566 | $31K |
| 43248 | 99 | 80 | $28K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 565 | 492 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,462 | 5,598 | $27K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2,933 | 2,466 | $27K |
| 83690 | 9,424 | 8,010 | $27K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,128 | 1,014 | $25K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 585 | 480 | $21K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,437 | 2,296 | $21K |
| 70450 | Computed tomography, head or brain; without contrast material | 846 | 698 | $19K |
| 81025 | 10,096 | 9,131 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 631 | 566 | $17K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 684 | 564 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,437 | 4,435 | $14K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,526 | 3,243 | $12K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 353 | 332 | $12K |
| 81001 | 19,108 | 16,501 | $11K | |
| 80061 | Lipid panel | 3,009 | 2,742 | $10K |
| 87081 | 2,875 | 2,642 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1,801 | 1,643 | $6K |
| 71046 | Radiologic examination, chest; 2 views | 1,633 | 1,378 | $6K |
| 76770 | 163 | 127 | $5K | |
| 45384 | 16 | 14 | $5K | |
| 74018 | 358 | 307 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 44 | 38 | $5K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 319 | 251 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,086 | 945 | $4K |
| 84702 | 374 | 331 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2,679 | 2,048 | $3K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 202 | 168 | $3K |
| 83735 | 1,152 | 873 | $3K | |
| 0002A | 97 | 75 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,906 | 1,740 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 183 | 166 | $2K |
| 64493 | 15 | 12 | $2K | |
| 85610 | 1,732 | 1,348 | $2K | |
| 74178 | 17 | 12 | $1K | |
| 76830 | Ultrasound, transvaginal | 24 | 24 | $1K |
| 85730 | 873 | 672 | $1K | |
| 95806 | 14 | 14 | $1K | |
| 0001A | 38 | 31 | $1K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 512 | 417 | $952.40 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 65 | 59 | $868.82 |
| 83970 | 32 | 28 | $788.03 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 25 | 24 | $600.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 4,833 | 4,187 | $568.41 |
| 81003 | 1,374 | 1,197 | $525.45 | |
| 83880 | 131 | 102 | $417.32 | |
| 85027 | 756 | 585 | $399.30 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,107 | 828 | $377.77 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 26 | 24 | $364.56 |
| 83605 | 93 | 65 | $358.70 | |
| 82657 | 698 | 576 | $314.88 | |
| 11045 | 25 | 12 | $307.53 | |
| 82248 | 369 | 334 | $292.42 | |
| 82550 | 143 | 113 | $277.76 | |
| 82077 | 58 | 52 | $272.95 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,034 | 1,557 | $231.55 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 5,702 | 4,578 | $199.64 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 149 | 108 | $194.60 |
| 84460 | 265 | 250 | $161.28 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 215 | 177 | $153.06 |
| 84144 | 17 | 13 | $151.96 | |
| 84450 | 173 | 162 | $135.36 | |
| 94760 | 252 | 83 | $134.54 | |
| 82728 | 29 | 27 | $118.72 | |
| 82962 | 3,082 | 1,601 | $107.59 | |
| 83516 | 48 | 26 | $106.93 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 12 | 12 | $103.68 |
| J1170 | Injection, hydromorphone, up to 4 mg | 277 | 204 | $97.62 |
| 84100 | 104 | 56 | $96.12 | |
| 88342 | 1,958 | 1,594 | $90.40 | |
| J2704 | Injection, propofol, 10 mg | 14,127 | 10,865 | $80.49 |
| 83540 | 41 | 39 | $77.44 | |
| 83550 | 29 | 27 | $76.32 | |
| 86140 | 47 | 41 | $75.58 | |
| 87070 | 232 | 152 | $75.00 | |
| 96376 | 53 | 29 | $71.22 | |
| 86850 | 13 | 12 | $70.37 | |
| J1644 | Injection, heparin sodium, per 1000 units | 468 | 330 | $64.20 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 8,160 | 7,076 | $61.59 |
| 81000 | 28 | 27 | $53.35 | |
| 84481 | 14 | 13 | $46.15 | |
| 80305 | 16 | 13 | $40.41 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 78 | 66 | $39.73 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | 1,040 | 813 | $32.63 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 24 | 19 | $29.84 |
| 82043 | 40 | 38 | $25.20 | |
| 84439 | 14 | 13 | $24.55 | |
| 82570 | 21 | 20 | $16.92 | |
| 80076 | 14 | 14 | $4.45 | |
| 91300 | 95 | 91 | $0.06 | |
| C1769 | Guide wire | 398 | 325 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 260 | 209 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 86 | 65 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 113 | 97 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 47 | 37 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 34 | 25 | $0.00 |
| 80320 | 14 | 12 | $0.00 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 669 | 495 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,659 | 2,155 | $0.00 |
| 99152 | 562 | 409 | $0.00 | |
| 88313 | 107 | 79 | $0.00 | |
| 87329 | 24 | 15 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 49 | 38 | $0.00 |
| 87324 | 24 | 15 | $0.00 | |
| 87328 | 24 | 15 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 22 | 12 | $0.00 |
| 83630 | 24 | 15 | $0.00 |